NCT03926455View on ClinicalTrials.gov

Safety and Immunogenicity of Typhax, a Typhoid Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 28, 2016

Primary Completion Date

February 15, 2017

Study Completion Date

February 15, 2017

Conditions
Typhoid Fever
Interventions
BIOLOGICAL

Typhax (investigational typhoid fever candidate vaccine)

BIOLOGICAL

Placebo

Placebo is administered to the control group on Day 0 and 28

BIOLOGICAL

Active Comparator Typhim Vi

A single dose of commercial typhoid fever vaccine Typhim Vi is administered on Day 0, followed by placebo control on Day 28

Sponsors
All Listed Sponsors
lead

Matrivax Research and Development Corporation

INDUSTRY